Cory Renauer, The Motley Fool
Sun, May 31, 2026 astatine 10:22 AM CDT 4 min read
Progyny (NASDAQ:PGNY) delivers fertility benefits to large employers; a cardinal insider precocious trimmed their stake, according to SEC filings.
Kevin K. Gordon, Director astatine Progyny, reported the merchantability of 5,500 shares of communal banal for a transaction worth of astir $137,000 connected May 27, 2026, according to the SEC Form 4 filing.
Transaction summary
| Shares sold (direct) | 5,500 |
| Transaction value | ~$137K |
| Post-transaction shares (direct) | 6,792 |
| Post-transaction shares (indirect) | 15,027 |
| Post-transaction worth (direct ownership) | ~$173K |
Transaction worth based connected SEC Form 4 weighted mean acquisition terms ($24.99); post-transaction worth based connected May 27, 2026 marketplace adjacent ($24.99).
Key questions
-
How does this merchantability comparison to Gordon’s humanities trading pattern?
Since May of past year, Gordon has made 2 income totaling 8,000 shares; this 5,500-share merchantability is his largest to day and brings his nonstop holdings down to little than 1 4th of the level held 12 months prior. -
What proportionality of Gordon’s wide Progyny presumption does this transaction represent?
The merchantability accounted for 20.13% of his nonstop holdings and combined nonstop and indirect ownership instantly earlier the transaction, with each indirect shares retained successful trust. -
Did the merchantability impact Gordon’s indirect holdings oregon lone his idiosyncratic account?
Only straight held shares were sold; each 15,027 indirect shares stay held by the Kevin Gordon Revocable Declaration of Trust, for which Gordon acts arsenic trustee. -
What does the timing and size of this transaction suggest astir aboriginal activity?
The elevated proportionality of nonstop shares sold reflects a shrinking disposable nonstop stock basal pursuing a bid of dispositions, alternatively than a displacement successful transaction cadence oregon intent.
Company overview
| Revenue (TTM) | $1.29 billion |
| Net income (TTM) | $67.69 million |
| Price (as of marketplace adjacent 5/29/26) | $25.56 |
| 1-year terms change | 16.2% |
* 1-year terms alteration calculated utilizing May 29, 2026, arsenic the notation date.
Company snapshot
-
Progyny offers fertility and family-building benefits solutions, including program design, concierge subordinate support, a selective web of fertility specialists, and integrated pharmacy benefits done Progyny Rx.
-
The institution generates gross by providing broad fertility benefits absorption services and pharmacy solutions to employers connected a contractual basis.
-
Primary customers are ample employers seeking to connection precocious fertility, surrogacy, and adoption reimbursement programs to their employees successful the United States.
Progyny is simply a starring benefits absorption institution specializing successful fertility and family-building solutions for employers crossed the United States. With implicit $1.29 cardinal successful TTM gross and a scalable concern model, Progyny leverages a differentiated web of specialists and integrated pharmacy offerings to code analyzable reproductive wellness needs. The company's absorption connected tailored benefits and high-touch enactment provides a competitory borderline successful the rapidly evolving healthcare benefits sector.

1 hour ago
2




English (CA) ·
English (US) ·
Spanish (MX) ·